Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:06 pm Purchase | 2021-12-31 | 13G | Teladoc Health, Inc. TDOC | ARK Investment Management LLC | 18,922,198 11.820% | 3,279,390 (+20.96%) | Filing History |
| 2022-02-09 3:04 pm Purchase | 2021-12-31 | 13G | Surface Oncology, Inc. SURF | ARK Investment Management LLC | 5,326,127 11.540% | 849,707 (+18.98%) | Filing History |
| 2022-02-09 3:02 pm Purchase | 2021-12-31 | 13G | Stratasys Ltd. SSYS | ARK Investment Management LLC | 7,654,932 11.690% | 280,431 (+3.80%) | Filing History |
| 2022-02-09 3:00 pm Purchase | 2021-12-31 | 13G | Signify Health, Inc. SGFY | ARK Investment Management LLC | 20,010,328 11.740% | 2,076,338 (+11.58%) | Filing History |
| 2022-02-09 2:59 pm Purchase | 2021-12-31 | 13G | Quantum-Si incorporated QSI | ARK Investment Management LLC | 13,067,150 11.120% | 1,404,125 (+12.04%) | Filing History |
| 2022-02-09 2:48 pm Sale | 2021-12-31 | 13G | Personalis, Inc. PSNL | ARK Investment Management LLC | 4,888,115 10.910% | -1,890,508 (-27.89%) | Filing History |
| 2022-02-09 2:47 pm Purchase | 2021-12-31 | 13G | PagerDuty, Inc. PD | ARK Investment Management LLC | 10,020,916 11.650% | 23,948 (+0.24%) | Filing History |
| 2022-02-09 2:45 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 26,383,103 11.960% | -2,121,526 (-7.44%) | Filing History |
| 2022-02-09 2:44 pm Purchase | 2021-12-31 | 13G | Materialise N.V. MTLS | ARK Investment Management LLC | 6,128,880 11.310% | 518,067 (+9.23%) | Filing History |
| 2022-02-09 2:42 pm Sale | 2021-12-31 | 13G | Iridium Communications Inc. IRDM | ARK Investment Management LLC | 10,136,671 7.670% | -3,513,207 (-25.74%) | Filing History |
| 2022-02-09 2:40 pm Purchase | 2021-12-31 | 13G | Invitae Corporation NVTAQ | ARK Investment Management LLC | 26,700,813 11.800% | 782,927 (+3.02%) | Filing History |
| 2022-02-09 2:38 pm Purchase | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 7,916,882 10.640% | 274,430 (+3.59%) | Filing History |
| 2022-02-09 2:37 pm Sale | 2021-12-31 | 13G | Fate Therapeutics, Inc. FATE | ARK Investment Management LLC | 10,312,167 10.800% | -478,256 (-4.43%) | Filing History |
| 2022-02-09 2:35 pm Sale | 2021-12-31 | 13G | Evogene Ltd. EVGN | ARK Investment Management LLC | 251,566 6.010% | -207,884 (-45.25%) | Filing History |
| 2022-02-09 2:32 pm Sale | 2021-12-31 | 13G | Editas Medicine, Inc. EDIT | ARK Investment Management LLC | 4,218,302 6.170% | -5,907,262 (-58.34%) | Filing History |
| 2022-02-09 2:31 pm Sale | 2021-12-31 | 13G | Dynamics Special Purpose Corp. DYNS | ARK Investment Management LLC | 2,362,677 9.960% | -15,026 (-0.63%) | Filing History |
| 2022-02-09 2:29 pm Purchase | 2021-12-31 | 13G | CRISPR Therapeutics AG CRSP | ARK Investment Management LLC | 9,087,868 11.880% | 1,443,518 (+18.88%) | Filing History |
| 2022-02-09 2:27 pm Sale | 2021-12-31 | 13G | Concord Acquisition Corp CND | ARK Investment Management LLC | 3,172,501 11.190% | -139,783 (-4.22%) | Filing History |
| 2022-02-09 2:26 pm Sale | 2021-12-31 | 13G | Compugen Ltd. CGEN | ARK Investment Management LLC | 9,222,415 10.990% | -7,860,891 (-46.02%) | Filing History |
| 2022-02-09 2:24 pm Unchanged | 2021-12-31 | 13G | Codexis, Inc. CDXS | ARK Investment Management LLC | 3,244,040 5.000% | 0 (Unchanged) | Filing History |